{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:30:13Z","timestamp":1790814613301,"version":"4.1.0"},"reference-count":168,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Parkinson\u2019s disease (PD) is the second most common neurodegenerative disorder, characterized by the progressive loss of dopaminergic neurons in the substantia nigra (SN) and the abnormal aggregation of \u03b1-synuclein (\u03b1-syn). PD exhibits features of a chronic inflammatory disease, significantly affecting peripheral organs and the central nervous system (CNS). Clinical signs include motor symptoms such as rigidity, bradykinesia, and tremor, as well as non-motor symptoms such as psychological and cognitive issues. Microglia are resident immune cells of the CNS, exhibiting high heterogeneity and playing a crucial role in the neuronal degeneration and inflammation associated with PD. In PD, microglia play dual roles: maintaining PD homeostasis by phagocytosing and clearing \u03b1-syn aggregates while simultaneously becoming dysfunctional due to aggregate overload. This dysfunction drives their transition to a pro-inflammatory phenotype, exacerbating neurotoxicity. Recently, technological advances like single-cell transcriptomics have revealed the diverse functions and changing phenotypic lineages of microglia in PD, providing new insights into their mechanisms. This review systematically describes the biological traits of microglia and their functional, spatial, genetic, and gender-related differences in PD neurodegeneration. It summarizes new intervention and treatment strategies targeting microglia, highlights recent progress and challenges in preclinical research and clinical trials, and offers guidance for developing precision therapies for PD focused on modulating microglial function.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1739341","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:45:45Z","timestamp":1770273945000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Microglia heterogeneity and therapeutic strategies in Parkinson\u2019s disease"],"prefix":"10.3389","volume":"17","author":[{"given":"Jing","family":"Tian","sequence":"first","affiliation":[{"name":"Department of Neurology, The First Automotive Works (FAW) Hospital","place":["Changchun, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehui","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Infection Control Office, The First Automotive Works (FAW) Hospital","place":["Changchun, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoqun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Automotive Works (FAW) Hospital","place":["Changchun, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Automotive Works (FAW) Hospital","place":["Changchun, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlei","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The First Automotive Works (FAW) Hospital","place":["Changchun, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First Automotive Works (FAW) Hospital","place":["Changchun, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(24)00038-3","article-title":"Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"23","year":"2024","journal-title":"Lancet Neurol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S1474-4422(21)00330-6","article-title":"The neuropsychiatry of Parkinson\u2019s disease: advances and challenges","volume":"21","author":"Weintraub","year":"2022","journal-title":"Lancet Neurol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41582-024-01043-w","article-title":"\u03b1-Synuclein pathology as a target in neurodegenerative diseases","volume":"21","author":"Park","year":"2025","journal-title":"Nat Rev Neurol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adk3225","article-title":"Central and peripheral innate and adaptive immunity in Parkinson\u2019s disease","volume":"15","author":"Harms","year":"2023","journal-title":"Sci Transl Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.immuni.2024.03.010","article-title":"Innate immune activation in neurodegenerative diseases","volume":"57","author":"Castro-Gomez","year":"2024","journal-title":"Immunity"},{"key":"B7","first-page":"483","article-title":"Deep-brain stimulation for Parkinson\u2019s disease","volume":"368","author":"Vidal","year":"2013","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrev.3c00479","article-title":"Parkinson\u2019s disease: advances in treatment and the syntheses of various classes of pharmaceutical drug substances","volume":"123","author":"Hill","year":"2023","journal-title":"Chem Rev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awac012","article-title":"A brain network for deep brain stimulation induced cognitive decline in Parkinson\u2019s disease","volume":"145","author":"Reich","year":"2022","journal-title":"Brain"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awt151","article-title":"Relation of lead trajectory and electrode position to neuropsychological outcomes of subthalamic neurostimulation in Parkinson\u2019s disease: results from a randomized trial","volume":"136","author":"Witt","year":"2013","journal-title":"Brain"},{"key":"B12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41588-023-01632-3","article-title":"Gene therapy for Parkinson\u2019s disease models","volume":"56","author":"Faial","year":"2024","journal-title":"Nat Genet"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1126\/science.aax6752","article-title":"Microglia monitor and protect neuronal function through specialized somatic purinergic junctions","volume":"367","author":"Cser\u00e9p","year":"2020","journal-title":"Science"},{"key":"B14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12974-023-02723-y","article-title":"The reciprocal interactions between microglia and T cells in Parkinson\u2019s disease: a double-edged sword","volume":"20","author":"Xu","year":"2023","journal-title":"J Neuroinflammation"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1126\/science.aat0474","article-title":"Microglia and early brain development: An intimate journey","volume":"362","author":"Thion","year":"2018","journal-title":"Science"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1126\/science.1202529","article-title":"Synaptic pruning by microglia is necessary for normal brain development","volume":"333","author":"Paolicelli","year":"2011","journal-title":"Science"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2025847118","article-title":"Soluble \u03b1-synuclein-antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia","volume":"118","author":"Trudler","year":"2021","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B18","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl Neurodegener"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2022.10.020","article-title":"Microglia states and nomenclature: A field at its crossroads","volume":"110","author":"Paolicelli","year":"2022","journal-title":"Neuron"},{"key":"B20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.molmed.2020.09.001","article-title":"Redefining microglial identity in health and disease at single-cell resolution","volume":"27","author":"Provenzano","year":"2021","journal-title":"Trends Mol Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-018-0176-3","article-title":"The mysterious origins of microglia","volume":"21","author":"Ginhoux","year":"2018","journal-title":"Nat Neurosci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29767","article-title":"Microglial activation and progression of nigrostriatal dysfunction in isolated REM sleep behavior disorder","volume":"39","author":"St\u00e6r","year":"2024","journal-title":"Mov Disord"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41583-018-0057-5","article-title":"Microglial signatures and their role in health and disease","volume":"19","author":"Butovsky","year":"2018","journal-title":"Nat Rev Neurosci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1126\/science.1194637","article-title":"Fate mapping analysis reveals that adult microglia derive from primitive macrophages","volume":"330","author":"Ginhoux","year":"2010","journal-title":"Science"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-024-01329-y","article-title":"The m(6)A methyltransferase METTL3 drives neuroinflammation and neurotoxicity through stabilizing BATF mRNA in microglia","volume":"32","author":"Wu","year":"2025","journal-title":"Cell Death Differ"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad8670","article-title":"Microglia development follows a stepwise program to regulate brain homeostasis","volume":"353","author":"Matcovitch-Natan","year":"2016","journal-title":"Science"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/nn.4338","article-title":"A polarizing question: do M1 and M2 microglia exist","volume":"19","author":"Ransohoff","year":"2016","journal-title":"Nat Neurosci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-019-0511-3","article-title":"Neuronal network activity controls microglial process surveillance in awake mice via norepinephrine signaling","volume":"22","author":"Liu","year":"2019","journal-title":"Nat Neurosci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1126\/science.1110647","article-title":"Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo","volume":"308","author":"Nimmerjahn","year":"2005","journal-title":"Science"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3102","article-title":"Innate immunity in Alzheimer\u2019s disease","volume":"16","author":"Heneka","year":"2015","journal-title":"Nat Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009076","article-title":"Biology of the TAM receptors","volume":"5","author":"Lemke","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/nrn.2016.7","article-title":"TREM2 variants: new keys to decipher Alzheimer disease pathogenesis","volume":"17","author":"Colonna","year":"2016","journal-title":"Nat Rev Neurosci"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2007.07.007","article-title":"Neurotransmitter receptors on microglia","volume":"30","author":"Pocock","year":"2007","journal-title":"Trends Neurosci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nn.4222","article-title":"Microglial brain region-dependent diversity and selective regional sensitivities to aging","volume":"19","author":"Grabert","year":"2016","journal-title":"Nat Neurosci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-051116-052358","article-title":"Microglia function in the central nervous system during health and neurodegeneration","volume":"35","author":"Colonna","year":"2017","journal-title":"Annu Rev Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-021-02268-5","article-title":"Periphery and brain, innate and adaptive immunity in Parkinson\u2019s disease","volume":"141","author":"Harms","year":"2021","journal-title":"Acta Neuropathol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/s41467-020-15119-w","article-title":"Microglia clear neuron-released \u03b1-synuclein via selective autophagy and prevent neurodegeneration","volume":"11","author":"Choi","year":"2020","journal-title":"Nat Commun"},{"key":"B39","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1016\/j.neuron.2024.06.029","article-title":"Microglia rescue neurons from aggregate-induced neuronal dysfunction and death through tunneling nanotubes","volume":"112","author":"Scheiblich","year":"2024","journal-title":"Neuron"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(23)00109-6","article-title":"Assessment of heterogeneity among participants in the Parkinson\u2019s Progression Markers Initiative cohort using \u03b1-synuclein seed amplification: a cross-sectional study","volume":"22","author":"Siderowf","year":"2023","journal-title":"Lancet Neurol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B42","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/ana.25557","article-title":"Increased immune activation by pathologic \u03b1-synuclein in parkinson\u2019s disease","volume":"86","author":"Grozdanov","year":"2019","journal-title":"Ann Neurol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.5c01068","article-title":"Inhibiting immune crosstalk by modulation of the intracellular function and extracellular environment of diseased microglia to boost parkinson\u2019s disease therapy","volume":"19","author":"Zheng","year":"2025","journal-title":"ACS Nano"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-024-01775-4","article-title":"Modeling Parkinson\u2019s disease pathology in human dopaminergic neurons by sequential exposure to \u03b1-synuclein fibrils and proinflammatory cytokines","volume":"27","author":"Bayati","year":"2024","journal-title":"Nat Neurosci"},{"key":"B45","doi-asserted-by":"publisher","first-page":"156146","DOI":"10.1016\/j.phymed.2024.156146","article-title":"Lignans of Schisandra chinensis (Turcz.) Baill inhibits Parkinson\u2019s disease progression through mediated neuroinflammation-TRPV1 expression in microglia","volume":"135","author":"Wang","year":"2024","journal-title":"Phytomedicine"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-020-0344-4","article-title":"Parkinson disease and the immune system - associations, mechanisms and therapeutics","volume":"16","author":"Tan","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.03.010","article-title":"A developmental switch in microglial HDAC function","volume":"48","author":"Mathys","year":"2018","journal-title":"Immunity"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-024-01764-7","article-title":"A cross-disease resource of living human microglia identifies disease-enriched subsets and tool compounds recapitulating microglial states","volume":"27","author":"Tuddenham","year":"2024","journal-title":"Nat Neurosci"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1126\/science.aat7554","article-title":"Single-cell profiling identifies myeloid cell subsets with distinct fates during neuroinflammation","volume":"363","author":"Jord\u00e3o","year":"2019","journal-title":"Science"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A unique microglia type associated with restricting development of alzheimer\u2019s disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"key":"B52","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.neuron.2018.12.006","article-title":"Developmental heterogeneity of microglia and brain myeloid cells revealed by deep single-cell RNA sequencing","volume":"101","author":"Li","year":"2019","journal-title":"Neuron"},{"key":"B53","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.imlet.2022.04.001","article-title":"Life and death of microglia: Mechanisms governing microglial states and fates","volume":"245","author":"Matsudaira","year":"2022","journal-title":"Immunol Lett"},{"key":"B54","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12974-025-03428-0","article-title":"Microglia efferocytosis: an emerging mechanism for the resolution of neuroinflammation in Alzheimer\u2019s disease","volume":"22","author":"Chen","year":"2025","journal-title":"J Neuroinflammation"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.05.003","article-title":"Disease-associated microglia: A universal immune sensor of neurodegeneration","volume":"173","author":"Deczkowska","year":"2018","journal-title":"Cell"},{"key":"B56","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12974-022-02496-w","article-title":"The role of Toll-like receptors and neuroinflammation in Parkinson\u2019s disease","volume":"19","author":"Heidari","year":"2022","journal-title":"J Neuroinflammation"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2025.02.013","article-title":"Dectin-1 participates in neuroinflammation and dopaminergic neurodegeneration through synergistic signaling crosstalk with TLR4","volume":"126","author":"Xue","year":"2025","journal-title":"Brain Behav Immun"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/glia.23970","article-title":"\u03b1-Synuclein evokes NLRP3 inflammasome-mediated IL-1\u03b2 secretion from primary human microglia","volume":"69","author":"Pike","year":"2021","journal-title":"Glia"},{"key":"B59","doi-asserted-by":"publisher","first-page":"103787","DOI":"10.1016\/j.redox.2025.103787","article-title":"Decoding Parkinson\u2019s Disease: The interplay of cell death pathways, oxidative stress, and therapeutic innovations","volume":"85","author":"Liu","year":"2025","journal-title":"Redox Biol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-025-01638-z","article-title":"NADPH acts as an endogenous P2X7 receptor modulator to gate neuroinflammatory responses of microglia","author":"Mou","year":"2025","journal-title":"Acta Pharmacol Sin"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2100035","article-title":"Microglial NLRP3 inflammasome activation upon TLR2 and TLR5 ligation by distinct \u03b1-synuclein assemblies","volume":"207","author":"Scheiblich","year":"2021","journal-title":"J Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adm8563","article-title":"Microglia-specific IL-10 gene delivery inhibits neuroinflammation and neurodegeneration in a mouse model of Parkinson\u2019s disease","volume":"16","author":"Bido","year":"2024","journal-title":"Sci Transl Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e2108435","DOI":"10.1002\/adma.202108435","article-title":"Controlled activation of TRPV1 channels on microglia to boost their autophagy for clearance of alpha-synuclein and enhance therapy of parkinson\u2019s disease","volume":"34","author":"Yuan","year":"2022","journal-title":"Adv Mater"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-0924-x","article-title":"Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution","volume":"566","author":"Masuda","year":"2019","journal-title":"Nature"},{"key":"B65","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41593-018-0290-2","article-title":"Human microglia regional heterogeneity and phenotypes determined by multiplexed single-cell mass cytometry","volume":"22","author":"B\u00f6ttcher","year":"2019","journal-title":"Nat Neurosci"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-023-00363-8","article-title":"Human striatal glia differentially contribute to AD- and PD-specific neurodegeneration","volume":"3","author":"Xu","year":"2023","journal-title":"Nat Aging"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-019-0532-y","article-title":"Mapping microglia states in the human brain through the integration of high-dimensional techniques","volume":"22","author":"Sankowski","year":"2019","journal-title":"Nat Neurosci"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2011.01.032","article-title":"Impaired CD200-CD200R-mediated microglia silencing enhances midbrain dopaminergic neurodegeneration: roles of aging, superoxide, NADPH oxidase, and p38 MAPK","volume":"50","author":"Wang","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0143-07.2008","article-title":"Neuroinflammation and oxidation\/nitration of alpha-synuclein linked to dopaminergic neurodegeneration","volume":"28","author":"Gao","year":"2008","journal-title":"J Neurosci"},{"key":"B70","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41588-021-00976-y","article-title":"Genetic analysis of the human microglial transcriptome across brain regions, aging and disease pathologies","volume":"54","author":"Lopes","year":"2022","journal-title":"Nat Genet"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1002\/glia.24295","article-title":"Microglia and astrocyte activation is region-dependent in the \u03b1-synuclein mouse model of Parkinson\u2019s disease","volume":"71","author":"Basurco","year":"2023","journal-title":"Glia"},{"key":"B72","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13024-019-0335-3","article-title":"Microglia affect \u03b1-synuclein cell-to-cell transfer in a mouse model of Parkinson\u2019s disease","volume":"14","author":"George","year":"2019","journal-title":"Mol Neurodegener"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2012.12.023","article-title":"Microglia: new roles for the synaptic stripper","volume":"77","author":"Kettenmann","year":"2013","journal-title":"Neuron"},{"key":"B74","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13024-019-0314-8","article-title":"Glial phagocytic clearance in Parkinson\u2019s disease","volume":"14","author":"Tremblay","year":"2019","journal-title":"Mol Neurodegener"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/nn.4325","article-title":"Age-related myelin degradation burdens the clearance function of microglia during aging","volume":"19","author":"Safaiyan","year":"2016","journal-title":"Nat Neurosci"},{"key":"B76","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.immuni.2018.11.004","article-title":"Single-cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell-state changes","volume":"50","author":"Hammond","year":"2019","journal-title":"Immunity"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/nn.4597","article-title":"Transcriptomic analysis of purified human cortical microglia reveals age-associated changes","volume":"20","author":"Galatro","year":"2017","journal-title":"Nat Neurosci"},{"key":"B78","doi-asserted-by":"publisher","first-page":"115618","DOI":"10.1016\/j.celrep.2025.115618","article-title":"Pathological \u03b1-synuclein dysregulates epitranscriptomic writer METTL3 to drive neuroinflammation in microglia","volume":"44","author":"Miller","year":"2025","journal-title":"Cell Rep"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30287-X","article-title":"The genetic architecture of Parkinson\u2019s disease","volume":"19","author":"Blauwendraat","year":"2020","journal-title":"Lancet Neurol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-024-00583-6","article-title":"A single-nuclei paired multiomic analysis of the human midbrain reveals age- and Parkinson\u2019s disease-associated glial changes","volume":"4","author":"Adams","year":"2024","journal-title":"Nat Aging"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.01.010","article-title":"Microglia heterogeneity in the single-cell era","volume":"30","author":"Masuda","year":"2020","journal-title":"Cell Rep"},{"key":"B82","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1016\/j.celrep.2018.08.001","article-title":"Transcriptional and translational differences of microglia from male and female brains","volume":"24","author":"Guneykaya","year":"2018","journal-title":"Cell Rep"},{"key":"B83","doi-asserted-by":"publisher","first-page":"109228","DOI":"10.1016\/j.celrep.2021.109228","article-title":"Replicative senescence dictates the emergence of disease-associated microglia and contributes to A\u03b2 pathology","volume":"35","author":"Hu","year":"2021","journal-title":"Cell Rep"},{"key":"B84","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.immuni.2024.01.008","article-title":"Fate mapping of Spp1 expression reveals age-dependent plasticity of disease-associated microglia-like cells after brain injury","volume":"57","author":"Lan","year":"2024","journal-title":"Immunity"},{"key":"B85","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.3233\/JPD-179009","article-title":"The birth of the modern era of parkinson\u2019s disease genetics","volume":"7","author":"Singleton","year":"2017","journal-title":"J Parkinsons Dis"},{"key":"B86","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1210\/er.2016-1007","article-title":"Estrogens, neuroinflammation, and neurodegeneration","volume":"37","author":"Villa","year":"2016","journal-title":"Endocr Rev"},{"key":"B87","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1093\/hmg\/ddab294","article-title":"Fine-mapping of Parkinson\u2019s disease susceptibility loci identifies putative causal variants","volume":"31","author":"Schilder","year":"2022","journal-title":"Hum Mol Genet"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/33416","article-title":"Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism","volume":"392","author":"Kitada","year":"1998","journal-title":"Nature"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1126\/science.1096284","article-title":"Hereditary early-onset Parkinson\u2019s disease caused by mutations in PINK1","volume":"304","author":"Valente","year":"2004","journal-title":"Science"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1126\/science.1077209","article-title":"Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism","volume":"299","author":"Bonifati","year":"2003","journal-title":"Science"},{"key":"B92","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12974-023-02776-z","article-title":"PARK7\/DJ-1 in microglia: implications in Parkinson\u2019s disease and relevance as a therapeutic target","volume":"20","author":"Lind-Holm Mogensen","year":"2023","journal-title":"J Neuroinflammation"},{"key":"B93","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/ana.10113","article-title":"A new locus for Parkinson\u2019s disease (PARK8) maps to chromosome 12p11.2-q13.1","volume":"51","author":"Funayama","year":"2002","journal-title":"Ann Neurol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab446","article-title":"Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state","volume":"145","author":"Smaji\u0107","year":"2022","journal-title":"Brain"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1403215111","article-title":"Abrogation of \u03b1-synuclein-mediated dopaminergic neurodegeneration in LRRK2-deficient rats","volume":"111","author":"Daher","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70117-0","article-title":"Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson\u2019s disease: a case-control study","volume":"7","author":"Healy","year":"2008","journal-title":"Lancet Neurol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13024-025-00880-7","article-title":"LRRK2 kinase activity regulates Parkinson\u2019s disease-relevant lipids at the lysosome","volume":"20","author":"Maloney","year":"2025","journal-title":"Mol Neurodegener"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29314","article-title":"Classification of GBA1 variants in parkinson\u2019s disease: the GBA1-PD browser","volume":"38","author":"Parlar","year":"2023","journal-title":"Mov Disord"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awp044","article-title":"Glucocerebrosidase mutations in clinical and pathologically proven Parkinson\u2019s disease","volume":"132","author":"Neumann","year":"2009","journal-title":"Brain"},{"key":"B100","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1750-1326-8-19","article-title":"TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson\u2019s disease","volume":"8","author":"Rayaprolu","year":"2013","journal-title":"Mol Neurodegener"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2014.1455","article-title":"APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease","volume":"71","author":"Mata","year":"2014","journal-title":"JAMA Neurol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","article-title":"The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases","volume":"47","author":"Krasemann","year":"2017","journal-title":"Immunity"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03835-z","article-title":"APOE \u03f54 carriers share immune-related proteomic changes across neurodegenerative diseases","volume":"31","author":"Shvetcov","year":"2025","journal-title":"Nat Med"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1002\/glia.23337","article-title":"Parkin deficiency modulates NLRP3 inflammasome activation by attenuating an A20-dependent negative feedback loop","volume":"66","author":"Mouton-Liger","year":"2018","journal-title":"Glia"},{"key":"B105","doi-asserted-by":"publisher","first-page":"e0175882","DOI":"10.1371\/journal.pone.0175882","article-title":"Parkinson\u2019s disease-associated genetic variation is linked to quantitative expression of inflammatory genes","volume":"12","author":"Pierce","year":"2017","journal-title":"PloS One"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-025-02099-0","article-title":"Long-read RNA sequencing atlas of human microglia isoforms elucidates disease-associated genetic regulation of splicing","volume":"57","author":"Humphrey","year":"2025","journal-title":"Nat Genet"},{"key":"B107","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.cell.2017.11.042","article-title":"Microbiome influences prenatal and adult microglia in a sex-specific manner","volume":"172","author":"Thion","year":"2018","journal-title":"Cell"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28312","article-title":"Differences in the presentation and progression of parkinson\u2019s disease by sex","volume":"36","author":"Iwaki","year":"2021","journal-title":"Mov Disord"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20211488","article-title":"The X factor in neurodegeneration","volume":"219","author":"Voskuhl","year":"2022","journal-title":"J Exp Med"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.05.048","article-title":"Sex-specific features of microglia from adult mice","volume":"23","author":"Villa","year":"2018","journal-title":"Cell Rep"},{"key":"B111","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/ana.26090","article-title":"Investigation of autosomal genetic sex differences in parkinson\u2019s disease","volume":"90","author":"Blauwendraat","year":"2021","journal-title":"Ann Neurol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.pneurobio.2016.04.006","article-title":"Microglial phenotypes in Parkinson\u2019s disease and animal models of the disease","volume":"155","author":"Joers","year":"2017","journal-title":"Prog Neurobiol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2019.1596481","article-title":"Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease","volume":"15","author":"Han","year":"2019","journal-title":"Autophagy"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aah4066","article-title":"Inflammasome inhibition prevents \u03b1-synuclein pathology and dopaminergic neurodegeneration in mice","volume":"10","author":"Gordon","year":"2018","journal-title":"Sci Transl Med"},{"key":"B115","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12974-025-03461-z","article-title":"Rebamipide (Mucosta\u00ae), a clinically approved drug, alleviates neuroinflammation and dopaminergic neurodegeneration in a Parkinson\u2019s disease model","volume":"22","author":"Lim","year":"2025","journal-title":"J Neuroinflammation"},{"key":"B116","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12974-023-02759-0","article-title":"Inflammasome inhibition protects dopaminergic neurons from \u03b1-synuclein pathology in a model of progressive Parkinson\u2019s disease","volume":"20","author":"Grotemeyer","year":"2023","journal-title":"J Neuroinflammation"},{"key":"B117","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12974-022-02410-4","article-title":"Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson\u2019s disease","volume":"19","author":"Pike","year":"2022","journal-title":"J Neuroinflammation"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awv184","article-title":"Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson\u2019s disease","volume":"138","author":"Jucaite","year":"2015","journal-title":"Brain"},{"key":"B119","doi-asserted-by":"publisher","first-page":"110358","DOI":"10.1016\/j.celrep.2022.110358","article-title":"Interleukin-6 triggers toxic neuronal iron sequestration in response to pathological \u03b1-synuclein","volume":"38","author":"Sterling","year":"2022","journal-title":"Cell Rep"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1172\/JCI136174","article-title":"Kv1.3 modulates neuroinflammation and neurodegeneration in Parkinson\u2019s disease","volume":"130","author":"Sarkar","year":"2020","journal-title":"J Clin Invest"},{"key":"B121","doi-asserted-by":"publisher","first-page":"6237","DOI":"10.1038\/s41467-021-26519-x","article-title":"Microglia-specific overexpression of \u03b1-synuclein leads to severe dopaminergic neurodegeneration by phagocytic exhaustion and oxidative toxicity","volume":"12","author":"Bido","year":"2021","journal-title":"Nat Commun"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20182191","article-title":"Fyn kinase regulates misfolded \u03b1-synuclein uptake and NLRP3 inflammasome activation in microglia","volume":"216","author":"Panicker","year":"2019","journal-title":"J Exp Med"},{"key":"B123","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12974-023-02732-x","article-title":"Integrin Mac1 mediates paraquat and maneb-induced learning and memory impairments in mice through NADPH oxidase-NLRP3 inflammasome axis-dependent microglial activation","volume":"20","author":"Hou","year":"2023","journal-title":"J Neuroinflammation"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-025-02331-3","article-title":"ACE2 alleviates microglia neuroinflammation by RANK-RANKL-OPG axis in parkinson\u2019s disease","author":"Xu","year":"2025","journal-title":"Inflammation"},{"key":"B125","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12974-023-02755-4","article-title":"NOD-like receptor NLRC5 promotes neuroinflammation and inhibits neuronal survival in Parkinson\u2019s disease models","volume":"20","author":"Liu","year":"2023","journal-title":"J Neuroinflammation"},{"key":"B126","doi-asserted-by":"publisher","first-page":"172639","DOI":"10.1016\/j.ejphar.2019.172639","article-title":"The effect of dextromethorphan use in Parkinson\u2019s disease: A 6-hydroxydopamine rat model and population-based study","volume":"862","author":"Liu","year":"2019","journal-title":"Eur J Pharmacol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2131-15.2015","article-title":"Selective VIP receptor agonists facilitate immune transformation for dopaminergic neuroprotection in MPTP-intoxicated mice","volume":"35","author":"Olson","year":"2015","journal-title":"J Neurosci"},{"key":"B128","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.tox.2014.02.009","article-title":"Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson\u2019s disease","volume":"319","author":"P\u00e9rez","year":"2014","journal-title":"Toxicology"},{"key":"B129","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12974-015-0320-x","article-title":"Lenalidomide reduces microglial activation and behavioral deficits in a transgenic model of Parkinson\u2019s disease","volume":"12","author":"Valera","year":"2015","journal-title":"J Neuroinflammation"},{"key":"B130","doi-asserted-by":"publisher","first-page":"101618","DOI":"10.1016\/j.arr.2022.101618","article-title":"Reducing neuroinflammation via therapeutic compounds and lifestyle to prevent or delay progression of Parkinson\u2019s disease","volume":"78","author":"Kip","year":"2022","journal-title":"Ageing Res Rev"},{"key":"B131","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41531-022-00394-9","article-title":"Cathepsin L-containing exosomes from \u03b1-synuclein-activated microglia induce neurotoxicity through the P2X7 receptor","volume":"8","author":"Jiang","year":"2022","journal-title":"NPJ Parkinsons Dis"},{"key":"B132","doi-asserted-by":"publisher","first-page":"5382","DOI":"10.1038\/s41467-021-25767-1","article-title":"Selective targeting of the TLR2\/MyD88\/NF-\u03baB pathway reduces \u03b1-synuclein spreading in vitro and in vivo","volume":"12","author":"Dutta","year":"2021","journal-title":"Nat Commun"},{"key":"B133","doi-asserted-by":"publisher","first-page":"e2413451","DOI":"10.1002\/advs.202413451","article-title":"Microglia process \u03b1-synuclein fibrils and enhance their pathogenicity in a TREM2-dependent manner","volume":"12","author":"Xiong","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B134","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13024-023-00686-5","article-title":"MLKL deficiency alleviates neuroinflammation and motor deficits in the \u03b1-synuclein transgenic mouse model of Parkinson\u2019s disease","volume":"18","author":"Geng","year":"2023","journal-title":"Mol Neurodegener"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0051-5","article-title":"Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson\u2019s disease","volume":"24","author":"Yun","year":"2018","journal-title":"Nat Med"},{"key":"B136","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neuroscience.2015.06.054","article-title":"Neuroprotective effects of lixisenatide and liraglutide in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson\u2019s disease","volume":"303","author":"Liu","year":"2015","journal-title":"Neuroscience"},{"key":"B137","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S1474-4422(23)00378-2","article-title":"Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson\u2019s disease: a randomised, double-blind, placebo-controlled trial","volume":"23","author":"McGarry","year":"2024","journal-title":"Lancet Neurol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"e047993","DOI":"10.1136\/bmjopen-2020-047993","article-title":"Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson\u2019s disease: protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: The \u2018Exenatide-PD3\u2019 study","volume":"11","author":"Vijiaratnam","year":"2021","journal-title":"BMJ Open"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)02808-3","article-title":"Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson\u2019s disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial","volume":"405","author":"Vijiaratnam","year":"2025","journal-title":"Lancet"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-191768","article-title":"The novel dual GLP-1\/GIP receptor agonist DA-CH5 is superior to single GLP-1 receptor agonists in the MPTP model of parkinson\u2019s disease","volume":"10","author":"Zhang","year":"2020","journal-title":"J Parkinsons Dis"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2312323","article-title":"Trial of lixisenatide in early parkinson\u2019s disease","volume":"390","author":"Meissner","year":"2024","journal-title":"N Engl J Med"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000201252.57661.e1","article-title":"A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease","volume":"66","year":"2006","journal-title":"Neurology"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2014.391","article-title":"Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience","volume":"71","author":"Parashos","year":"2014","journal-title":"JAMA Neurol"},{"key":"B144","doi-asserted-by":"publisher","first-page":"114689","DOI":"10.1016\/j.intimp.2025.114689","article-title":"Clinical study to investigate the adjuvant role of Pentoxifylline in patients with Parkinson\u2019s disease: A randomized controlled study","volume":"156","author":"Khrieba","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-024-01567-z","article-title":"Repurposing celecoxib as adjuvant therapy in patients with Parkinsonian disease: a new therapeutic dawn: randomized controlled pilot study","volume":"32","author":"Khrieba","year":"2024","journal-title":"Inflammopharmacology"},{"key":"B146","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41419-018-0468-2","article-title":"Taurine protects dopaminergic neurons in a mouse Parkinson\u2019s disease model through inhibition of microglial M1 polarization","volume":"9","author":"Che","year":"2018","journal-title":"Cell Death Dis"},{"key":"B147","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0111-4","article-title":"Modulation of M1\/M2 polarization by capsaicin contributes to the survival of dopaminergic neurons in the lipopolysaccharide-lesioned substantia nigra in vivo","volume":"50","author":"Bok","year":"2018","journal-title":"Exp Mol Med"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00133-2","article-title":"TREM2-mediated activation of microglia breaks link between amyloid and tau","volume":"20","author":"Hardy","year":"2021","journal-title":"Lancet Neurol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26157057","article-title":"TREM2 in neurodegenerative disorders: mutation spectrum, pathophysiology, and therapeutic targeting","volume":"26","author":"Yang","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B150","doi-asserted-by":"publisher","first-page":"132179","DOI":"10.1016\/j.ijbiomac.2024.132179","article-title":"Dihydroquercetin alleviates dopamine neuron loss via regulating TREM2 activation","volume":"269","author":"Yang","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"e2405364","DOI":"10.1002\/advs.202405364","article-title":"Nanotherapeutic approaches of interleukin-3 to clear the \u03b1-synuclein pathology in mouse models of parkinson\u2019s disease","volume":"11","author":"Zhang","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"B152","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12974-021-02267-z","article-title":"LncRNA HOXA-AS2 regulates microglial polarization via recruitment of PRC2 and epigenetic modification of PGC-1\u03b1 expression","volume":"18","author":"Yang","year":"2021","journal-title":"J Neuroinflammation"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.03.010","article-title":"Focused ultrasound-mediated cerium-based nanoreactor against Parkinson\u2019s disease via ROS regulation and microglia polarization","volume":"368","author":"Gao","year":"2024","journal-title":"J Control Release"},{"key":"B154","doi-asserted-by":"publisher","first-page":"e2105711","DOI":"10.1002\/adma.202105711","article-title":"Self-catalytic small interfering RNA nanocarriers for synergistic treatment of neurodegenerative diseases","volume":"34","author":"Ji","year":"2022","journal-title":"Adv Mater"},{"key":"B155","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of parkinson\u2019s disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"key":"B156","doi-asserted-by":"publisher","first-page":"e13094","DOI":"10.1111\/cpr.13094","article-title":"Partial depletion and repopulation of microglia have different effects in the acute MPTP mouse model of Parkinson\u2019s disease","volume":"54","author":"Li","year":"2021","journal-title":"Cell Prolif"},{"key":"B157","doi-asserted-by":"publisher","first-page":"7368","DOI":"10.1038\/s41467-025-62755-1","article-title":"Design of Ig-like binders targeting \u03b1-synuclein fibril for mitigating its pathological activities","volume":"16","author":"Zeng","year":"2025","journal-title":"Nat Commun"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2025.04.001","article-title":"The microglial lineage: present and beyond","volume":"46","author":"Chen","year":"2025","journal-title":"Trends Immunol"},{"key":"B159","doi-asserted-by":"publisher","first-page":"e2303789120","DOI":"10.1073\/pnas.2303789120","article-title":"LRRK2 suppresses lysosome degradative activity in macrophages and microglia through MiT-TFE transcription factor inhibition","volume":"120","author":"Yadavalli","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29297","article-title":"LRRK2 inhibition by BIIB122 in healthy participants and patients with parkinson\u2019s disease","volume":"38","author":"Jennings","year":"2023","journal-title":"Mov Disord"},{"key":"B161","doi-asserted-by":"publisher","first-page":"4470","DOI":"10.1038\/s41467-025-59249-5","article-title":"Intermittent fasting reduces alpha-synuclein pathology and functional decline in a mouse model of Parkinson\u2019s disease","volume":"16","author":"Szeg\u0151","year":"2025","journal-title":"Nat Commun"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson\u2019s disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol"},{"key":"B163","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41582-024-01046-7","article-title":"Immune mechanisms and shared immune targets in neurodegenerative diseases","volume":"21","author":"Weiner","year":"2025","journal-title":"Nat Rev Neurol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.125","article-title":"Microglia and macrophages in brain homeostasis and disease","volume":"18","author":"Li","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb8587","article-title":"Microglia modulate neurodegeneration in Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"370","author":"Bartels","year":"2020","journal-title":"Science"},{"key":"B166","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12974-025-03462-y","article-title":"Microglial dynamics and neuroinflammation in prodromal and early Parkinson\u2019s disease","volume":"22","author":"Lind-Holm Mogensen","year":"2025","journal-title":"J Neuroinflammation"},{"key":"B167","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40035-024-00402-3","article-title":"Emerging role of senescent microglia in brain aging-related neurodegenerative diseases","volume":"13","author":"Rim","year":"2024","journal-title":"Transl Neurodegener"},{"key":"B168","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40035-023-00368-8","article-title":"Animal models of Parkinson\u2019s disease: bridging the gap between disease hallmarks and research questions","volume":"12","author":"Dovonou","year":"2023","journal-title":"Transl Neurodegener"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1739341\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:57:36Z","timestamp":1771927056000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1739341\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":168,"alternative-id":["10.3389\/fimmu.2026.1739341"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1739341","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"article-number":"1739341"}}